Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,781 | -53,585 | -42,210 | -58,505 | -63,660 |
| Depreciation Amortization | 1,071 | 1,178 | 1,207 | 1,355 | 1,159 |
| Accounts receivable | -274 | N/A | N/A | 61 | -61 |
| Accounts payable and accrued liabilities | 1,132 | -201 | 263 | -1,304 | 1,160 |
| Other Working Capital | -5,022 | 1,549 | 768 | -3,716 | -6,197 |
| Other Operating Activity | 21,752 | 14,716 | 6,931 | 15,096 | 13,502 |
| Operating Cash Flow | $-54,122 | $-36,343 | $-33,041 | $-47,013 | $-54,097 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -315 | -125 | -121 | -401 | -437 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 8,000 |
| Purchase Sale Intangibles | -20 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -20 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-335 | $-125 | $-121 | $-401 | $7,563 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | -6 | 65,000 | 1,939 |
| Debt Repayment | N/A | N/A | N/A | -437 | -1,532 |
| Common Stock Issued | 17,154 | 110,422 | 16,394 | 15,376 | 62,510 |
| Other Financing Activity | 0 | -281 | 0 | 0 | -232 |
| Financing Cash Flow | $17,154 | $110,141 | $16,388 | $79,939 | $62,685 |
| Beginning Cash Position | 118,038 | 44,365 | 61,139 | 28,614 | 12,463 |
| End Cash Position | 80,735 | 118,038 | 44,365 | 61,139 | 28,614 |
| Net Cash Flow | $-37,303 | $73,673 | $-16,774 | $32,525 | $16,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,122 | -36,343 | -33,041 | -47,013 | -54,097 |
| Capital Expenditure | -315 | -125 | -121 | -401 | -437 |
| Free Cash Flow | -54,437 | -36,468 | -33,162 | -47,414 | -54,534 |